A unique microvascular phenotype shared by Juvenile hemangiomas and human placenta

Archives of Dermatology

Volumn 137, Issue 5, 2001, Pages 559-570

  North, Paula E ^a   Waner, Milton ^a   Mizeracki, Adam ^a   Mrak, Robert E ^a,b   Nicholas, Richard ^a   Kincannon, Jay ^a   Suen, James Y ^a   Mihm Jr , Martin C ^c  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; GLUCOSE TRANSPORTER; MEROSIN;

ANTIGEN EXPRESSION; ARTICLE; CAPILLARY HEMANGIOMA; CHILD; CHORION VILLUS; ELECTRON MICROSCOPY; FEMALE; HEMANGIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NEWBORN; PHENOTYPE; PLACENTA; PRIORITY JOURNAL; TISSUE SPECIFICITY;

BLOOD VESSELS; CEREBROVASCULAR CIRCULATION; CHILD; CHILD, PRESCHOOL; CHORIONIC VILLI; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HEMANGIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; LAMININ; LEWIS BLOOD-GROUP SYSTEM; MICROCIRCULATION; MONOSACCHARIDE TRANSPORT PROTEINS; PHENOTYPE; PLACENTA; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 0035007197     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31: 11-22.
2. Harik SI, Kalaria RN, Andersson L, Lundahl P, Perry G. Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functions. J Neurosci. 1990;10:3862-3872.
3. Froehner SC, Davies A, Baldwin SA, Lienhard GE. The blood-nerve barrier is rich in glucose transporter. J Neurocytol. 1988;17:173-178.
4. Jansson T, Wennergren M, Illsley NP. Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation. J Clin Endocrinol Metab. 1993;77:1554-1562.
5. Schlingemann RO, Hofman P, Klooster J, Blaauwgeers HG, Van der Gaag R, Vrensen GF. Ciliary muscle capillaries have blood-tissue barrier characteristics. Exp Eye Res. 1998;66:747-754.
6. Farrell CL, Yang J, Pardridge WM. GLUT-1 glucose transporter is present within apical and basolateral membranes of brain epithelial interfaces and in microvascular endothelia with and without tight junctions. J Histochem Cytochem. 1992; 40:193-199.
7. Iwata J, Sonobe H, Furihata M, Ido E, Ohtsuki Y. High frequency of apoptosis in infantile capillary haemangioma. J Pathol. 1996;179:403-408.
8. North PE, Mihm MC Jr. The surgical pathology approach to pediatric vascular tumors and anomalies. In: Waner M, Suen JY, eds. Hemangiomas and Vascular Malformations of the Head and Neck. New York, NY: John Wiley & Sons Inc; 1999:93-170.
9. Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J. Wide expression of the human erythrocyte glucose transporter GLUT1 in human cancers. Cancer Res. 1996;56:1164-1167.
10. Abe K, McKibbin JM, Hakomori S. The monoclonal antibody directed to difucosylated type 2 chain (Fuc alpha 1 leads to 2Gal beta 1 leads to 4[Fuc alpha 1 leads to 3]GlcNAc; Y determinant). J Biol Chem. 1983;258:11793-11797.
11. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol. 1990;43:752-757.
12. Sedmak DD, Davis DH, Singh U, van de Winkel JG, Anderson CL. Expression of IgG Fc receptor antigens in placenta and on endothelial cells in humans: an immunohistochemical study. Am J Pathol. 1991;138:175-181.
13. Engvall E, Earwicker D, Haaparanta T, Ruoslahti E, Sanes JR. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regulat. 1990;1:731-740.
14. Schlingemann RO, Dingjan GM, Emeis JJ, Blok J, Warnaar SO, Ruiter DJ. Monoclonal antibody PAL-E specific for endothelium. Lab Invest. 1985;52:71-76.
15. Maleville J, Taieb A, Roubaud E, Sarrat P, Fontan I, Guillet G. Hemangiomes cutanes immatures: étude epidemiologique de 351 cas. Ann Dermatol Venereol. 1985;112:603-608.
16. Jacobs AH. Strawberry hemangiomas: the natural history of the untreated lesion. Calif Med. 1957;86:8-10.
17. Ulvestad E, Williams K, Vedeler C, et al. Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. J Neurol Sci. 1994;121:125-131.
18. Sewry CA, D'Alessandro M, Wilson LA, et al. Expression of laminin chains in skin in merosin-deficient congenital muscular dystrophy. Neuropediatrics. 1997;28: 217-222.
19. Villanova M, Malandrini A, Toti P, et al. Localization of merosin in the normal human brain: implications for congenital muscular dystrophy with merosin deficiency. J Submicrosc Cytol Pathol. 1996;28:1-4.
20. Leivo I, Engvall E. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci U S A. 1988;85:1544-1548.
21. Voit T, Fardeau M, Tome FM. Prenatal detection of merosin expression in human placenta. Neuropediatrics. 1994;25:332-333.
22. Schlingemann RO, Bots GTAM, Van Duinen SG, Ruiter DJ. Differential expression of endothelium-specific antigen PAL-E in vasculature of brain tumors and preexistent brain capillaries. Ann N Y Acad Sci. 1988;529:111-114.
23. Kaplan P, Normandin J Jr, Wilson GN, Plauchu H, Lippman A, Vekemans M. Malformations and minor anomalies in children whose mothers had prenatal diagnosis: comparison between CVS and amniocentesis Am J Med Genet. 1990;37: 366-370.
24. Burton BK, Schulz CJ, Burd LI. Spectrum of limb disruption defects associated with chorionic villus sampling. Pediatrics. 1993;91:989-993.
25. Burton BK, Schulz CJ, Angle B, Burd LI. An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS). Prenat Diagn. 1995; 15:209-214.
26. Quintero RA, Romero R, Mahoney BS, Vecchio M, Holden J, Hobbins JC. Fetal haemorrhagic lesions after chorionic villus sampling. Lancet. 1992;339:193.
27. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta. 1997;18:657-665.
28. Clark DE, Smith SK, He Y, et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod. 1998;59:1540-1548.
29. Hornig C, Barleon B, Ahmad S, Vuorela P, Ahmed A, Weich HA. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest. 2000;80:443-454.
30. Banks RE, Forbes MA, Searles J, et al. Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Molec Hum Reprod. 1998;4:377-386.
31. Ziche M, Maglione D, Ribatti D, et al. Placenta growth factor-1 is chemofactic, mitogenic, and angiogenic. Lab Invest. 1997;76:517-531.
32. Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of accelerated involution. J Pediatr. 1996;128:329-335.
33. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol. 1995;11:73-91.
34. Noden DM. Embryonic origins and assembly of blood vessels. Am Rev Respir Dis. 1989;140:1097-1103.
35. Noden DM. Development of craniofacial blood vessels. In: Feinberg RN, Sherer GK, Auerbach R, eds. The Development of the Vascular System. Basel, Switzerland: Karger; 1991:1-23.
36. Gonzalez-Crussi F, Reyes-Mugica M. Cellular hemangiomas ("hemangioendotheliomas") in infants: light microscopic, immunohistochemical, and ultrastructural observations. Am J Surg Pathol. 1991;15:769-778.
37. Darland DC, D'Amore PA. Blood vessel maturation: vascular development comes of age. J Clin Invest. 1999;103:157-158.
38. Harik SI, Hall AK, Richey P, Andersson L, Lundahl P, Perry G. Ontogeny of the erythroid/HepG2-type glucose transporter (GLUT-1) in the rat nervous system. Brain Res Dev Brain Res. 1993;72:41-49.
39. Mantych GJ, Hageman GS, Devaskar SU. Characterization of glucose transporter isoforms in the adult and developing human eye. Endocrinology. 1993; 133:600-607.
40. Pardridge WM, Boado RJ, Farrell CR. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier: studies with quantitative Western blotting and in situ hybridization. J Biol Chem. 1990;265:18035-18040.
41. Carstensen M, Leichweiss HP, Molsen G, Schroder H. Evidence for a specific transport of D-hexoses across the human term placenta in vitro. Arch Gynakol. 1977;222:187-196.
42. Hahn T, Hartmann M, Blaschitz A, et al. Localisation of the high affinity facultative glucose transporter protein GLUT 1 in the placenta of human, marmoset monkey (Callithrix jacchus) and rat at different developmental stages. Cell Tissue Res. 1995;280:49-57.
43. Martin-Padura I, De Castellarnau C, Uccini S, et al. Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas. J Pathol. 1995;175:51-57.
44. Sewry CA, Philpot J, Sorokin LM, et al. Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy. Lancet. 1996;347:582-584.
45. Sanes JR, Engvall E, Butkowski R, Hunter DD. Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol. 1990;111:1685-1699.
46. Virtanen I, Laitinen L, Korhonen M. Differential expression of laminin polypeptides in developing and adult human kidney. J Histochem Cytochem. 1995;43: 621-628.
47. Vachon PH, Loechel F, Xu H, Wewer UM, Engvall E. Merosin and laminin in myogenesis: specific requirement for merosin in myotube stability and survival. J Cell Biol. 1996;134:1483-1497.
48. Tome FM, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III. 1994;317:351-357.
49. Lloyd KO. Philip Levine award lecture: blood group antigens as markers for normal differentiation and malignant change in human tissues. Am J Clin Pathol. 1987;87:129-139.
50. Zhu ZM, Kojima N, Stroud MR, Hakomori S, Fenderson BA. Monoclonal antibody directed to Le(y) oligosaccharide inhibits implantation in the mouse. Biol Reprod. 1995;52:903-912.
51. Wakabayashi M, Shiro T, Seki T, et al. Lewis Y antigen expression in hepatocellular carcinoma: an immunohistochemical study. Cancer. 1995;75:2827-2835.
52. Hiraishi K, Suzuki K, Hakomori S, Adachi M. Le(y) antigen expression is correlated with apoptosis (programmed cell death). Glycobiology. 1993;3:381-390.
53. Minamide S, Naora H, Adachi M, Okano A. Apoptosis as a mechanism of skin renewal: Le(y)-antigen expression is involved in an early event of a cell's commitment to apoptosis. Histochem Cell Biol. 1995;103:339-343.
54. Kuwashima Y, Kobayashi Y, Kawarai A, et al. Evaluation of apoptosis in human endometrial adenocarcinoma: comparison of nick end labeling and Le(y) antigen immunostaining method. Anticancer Res. 1996;16:3225-3228.
55. Pulford K, Ralfkiaer E, MacDonald SM, et al. A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes. Immunology. 1986;57:71-76.
56. Lang I, Hartmann M, Blaschitz A, Dohr G, Skofitsch G, Desoye G. Immunohistochemical evidence for the heterogeneity of maternal and fetal vascular endothelial cells in human full-term placenta. Cell Tissue Res. 1993;274:211-218.
57. Micklem KJ, Stross WP, Willis AC, Cordell JL, Jones M, Mason DY. Different isoforms of human FcγRII distinguished by CDw32 antibodies. J Immunol. 1990; 144:2295-2303.
58. Matre R, Johnson PM. Multiple Fc receptors in the human placenta. Acta Pathol Microbiol Scand C. 1977;85C:314-316.